Both tirzepatide and Mounjaro represent a new approach to addressing type 2 diabetes and obesity. Tirzepatide is a novel agonist that targets several metabolic pathways, such as GLP-1 and glucose-dependent https://elodiejqmm399531.alltdesign.com/understanding-tirzepatide-mounjaro-the-you-need-to-be-aware-of-62634005